BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24527758)

  • 41. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
    Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
    Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphism association of NIL1, NIL2, CYP1A1 xenobiotic metabolism genes and their expression with the risk of colorectal cancer in the Polish population.
    Kabziński J; Gogolewska M; Nowakowski M; Kucharska E; Dziki Ł; Mik M; Dziki A; Majsterek I
    Pol Przegl Chir; 2022 Mar; 94(2):54-59. PubMed ID: 35485310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CYP2D6 and CYP1A1 mutations in the Turkish population.
    Aydin M; Hatirnaz O; Erensoy N; Ozbek U
    Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    Datkhile KD; Patil SR; Patil MN; Durgawale PP; Jagdale NJ; Deshmukh VN; More AL; Gudur RA; Gudur AK
    J Cancer Res Ther; 2023 Oct; 19(7):1925-1930. PubMed ID: 38376298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
    Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Susceptibility genetic variants associated with early-onset colorectal cancer.
    Giráldez MD; López-Dóriga A; Bujanda L; Abulí A; Bessa X; Fernández-Rozadilla C; Muñoz J; Cuatrecasas M; Jover R; Xicola RM; Llor X; Piqué JM; Carracedo A; Ruiz-Ponte C; Cosme A; Enríquez-Navascués JM; Moreno V; Andreu M; Castells A; Balaguer F; Castellví-Bel S;
    Carcinogenesis; 2012 Mar; 33(3):613-9. PubMed ID: 22235025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
    Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
    Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of genetic variations of the CYP1A1, GSTT1, and GSTM1 genes on the risk of coronary artery disease.
    Taspinar M; Aydos S; Sakiragaoglu O; Duzen IV; Yalcinkaya A; Oztuna D; Bardakci H; Tutar E; Sunguroglu A
    DNA Cell Biol; 2012 Feb; 31(2):211-8. PubMed ID: 21848428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
    Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
    Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytochrome P450 gene polymorphism and cancer.
    Agundez JA
    Curr Drug Metab; 2004 Jun; 5(3):211-24. PubMed ID: 15180491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-nucleotide polymorphism in CYP1A1, CYP1B1, CYP2B6, CYP2C8, and CYP2C9 genes and their association with gastrointestinal cancer: A hospital-based case-control study.
    Patil MN; Datkhile KD; Gudur AK; Gudur RA; Patil SR
    J Cancer Res Ther; 2024 Jan; 20(1):216-223. PubMed ID: 38554324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between cytochrome P450 2C9 gene polymorphisms and colorectal cancer susceptibility: evidence from 16 case-control studies.
    Wang H; Ren L; He Y; Wei Y; Chen Z; Yang W; Fu Y; Xu X; Fu W; Hu G; Lou W
    Tumour Biol; 2014 May; 35(5):4317-22. PubMed ID: 24414392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CYP1A1 Ile462Val polymorphism and colorectal cancer risk in Polish patients.
    Gil J; Gaj P; Misiak B; Ostrowski J; Karpinski P; Jarczyńska A; Kielan W; Sasiadek MM
    Med Oncol; 2014 Jul; 31(7):72. PubMed ID: 24939416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low Variability and Stable Frequency of Common Haplotypes of the
    Škereňová M; Halašová E; Matáková T; Jesenská Ľ; Jurečeková J; Šarlinová M; Čierny D; Dobrota D
    Anticancer Res; 2017 Apr; 37(4):1901-1907. PubMed ID: 28373458
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, NSC 721648) sensitivity in breast and colorectal cancer cells.
    Tan BS; Tiong KH; Muruhadas A; Randhawa N; Choo HL; Bradshaw TD; Stevens MF; Leong CO
    Mol Cancer Ther; 2011 Oct; 10(10):1982-92. PubMed ID: 21831963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Genetic polymorphism of enzymes metabolizing xenobiotics as a factor in susceptibility to tumor development].
    Salagovic J; Kalina I; Dudas M
    Bratisl Lek Listy; 2000; 101(9):512-21. PubMed ID: 11187056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between PTEN IVS4 polymorphism and development of colorectal cancer in a Turkish population.
    Canbay E; Kahraman OT; Bugra D; Caykara B; Seyhan MF; Bulut T; Yamaner S; Ozturk O
    Expert Opin Ther Targets; 2013 Jan; 17(1):1-6. PubMed ID: 23062208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic variability in susceptibility and response to toxicants.
    Ingelman-Sundberg M
    Toxicol Lett; 2001 Mar; 120(1-3):259-68. PubMed ID: 11323184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma.
    Lin M; Eng C; Hawk ET; Huang M; Greisinger AJ; Gu J; Ellis LM; Wu X; Lin J
    Carcinogenesis; 2012 Apr; 33(4):841-7. PubMed ID: 22318908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.